Kura Oncology (KURA) Common Equity (2010 - 2026)
Kura Oncology (KURA) reported Common Equity of $107.9 million for Q1 2026, down 70.39% year-over-year from $364.4 million in Q1 2025, and down 38.05% on a QoQ basis from $174.1 million in Q4 2025.
Kura Oncology (KURA) has 17 years of Common Equity data on file, last reported at $107.9 million in Q1 2026.
- Quarterly Common Equity fell 70.39% year-over-year to $107.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $107.9 million (down 70.39% YoY) and the FY2025 annual result came in at $174.1 million, down 57.9% from the prior year.
- Common Equity fell to $107.9 million in Q1 2026 per KURA's latest filing, from $174.1 million in the prior quarter.
- Across five years, Common Equity topped out at $505.1 million in Q1 2024 and bottomed at $107.9 million in Q1 2026.
- The 5-year median for Common Equity is $419.6 million (2022), against an average of $379.5 million.
- The widest annual swing landed in 2024, when Common Equity increased 27.81%; it then slumped 70.39% in 2026.
- Tracing KURA's Common Equity over 5 years: stood at $420.3 million in 2022, then slipped by 5.47% to $397.3 million in 2023, then gained by 4.12% to $413.6 million in 2024, then slumped by 57.9% to $174.1 million in 2025, then slumped by 38.05% to $107.9 million in 2026.
- Per Business Quant, the three latest KURA Common Equity figures stand at $107.9 million (Q1 2026), $174.1 million (Q4 2025), and $242.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.42 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 35.63 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 13.21 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Kura Oncology | 801.92 Mn | 801.92 Mn | 18.00 Mn | 107.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 107.88 Mn |
| Dec 31, 2025 | 174.14 Mn |
| Sep 30, 2025 | 242.54 Mn |
| Jun 30, 2025 | 305.49 Mn |
| Mar 31, 2025 | 364.41 Mn |
| Dec 31, 2024 | 413.64 Mn |
| Sep 30, 2024 | 423.77 Mn |
| Jun 30, 2024 | 466.07 Mn |
| Mar 31, 2024 | 505.08 Mn |
| Dec 31, 2023 | 397.27 Mn |
| Sep 30, 2023 | 429.94 Mn |
| Jun 30, 2023 | 459.68 Mn |
| Mar 31, 2023 | 395.18 Mn |
| Dec 31, 2022 | 420.28 Mn |
| Sep 30, 2022 | 419.62 Mn |
| Jun 30, 2022 | 449.49 Mn |
| Mar 31, 2022 | 476.25 Mn |
| Dec 31, 2021 | 506.61 Mn |
| Sep 30, 2021 | 533.76 Mn |
| Jun 30, 2021 | 558.55 Mn |
| Mar 31, 2021 | 585.99 Mn |
| Dec 31, 2020 | 610.91 Mn |
| Sep 30, 2020 | 306.50 Mn |
| Jun 30, 2020 | 322.37 Mn |
| Mar 31, 2020 | 203.20 Mn |
| Dec 31, 2019 | 218.78 Mn |
| Sep 30, 2019 | 233.58 Mn |
| Jun 30, 2019 | 246.58 Mn |
| Mar 31, 2019 | 149.57 Mn |
| Dec 31, 2018 | 160.99 Mn |
| Sep 30, 2018 | 174.61 Mn |
| Jun 30, 2018 | 112.40 Mn |
| Mar 31, 2018 | 124.80 Mn |
| Dec 31, 2017 | 79.87 Mn |
| Sep 30, 2017 | 89.20 Mn |
| Jun 30, 2017 | 43.64 Mn |
| Mar 31, 2017 | 50.24 Mn |
| Dec 31, 2016 | 56.88 Mn |
| Sep 30, 2016 | 63.67 Mn |
| Jun 30, 2016 | 70.04 Mn |
| Mar 31, 2016 | 76.07 Mn |
| Dec 31, 2015 | 82.10 Mn |
| Sep 30, 2015 | 37.78 Mn |
| Jun 30, 2015 | 43.32 Mn |
| Mar 31, 2015 | 48.89 Mn |
| Dec 31, 2014 | -3.43 Mn |
| Sep 30, 2014 | -143,038.00 |
| Jun 30, 2014 | -136,610.00 |
| Mar 31, 2014 | -129,723.00 |
| Dec 31, 2013 | -123,957.00 |
| Sep 30, 2013 | -114,207.00 |
| Jun 30, 2013 | -108,068.00 |
| Mar 31, 2013 | -101,319.00 |
| Dec 31, 2012 | -95,346.00 |
| Sep 30, 2012 | -85,684.00 |
| Jun 30, 2012 | -79,671.00 |
| Mar 31, 2012 | -73,403.00 |
| Dec 31, 2011 | -68,031.00 |
| Sep 30, 2011 | -59,147.00 |
| Jun 30, 2011 | -52,880.00 |
| Mar 31, 2011 | -68,031.00 |
| Dec 31, 2010 | -40,991.00 |